The FDA’s repeated delays in banning formaldehyde from hair-straightening products have sparked significant concern among health advocates and lawmakers.
Missed Deadlines and Regulatory Delays
- Latest Missed Target: The FDA missed its most recent deadline of December 31, 2025, to propose a ban on formaldehyde and formaldehyde-releasing chemicals in hair-smoothing products.
- History of Postponements: This marks the sixth delay for a rule originally slated for October 2023. Subsequent deadlines in 2024 and 2025 have all passed without official action.
- Status in “Limbo”: While the FDA maintains the rule is a “priority,” there are no formal legal consequences for missing these dates, leaving the publication timeline uncertain.
Health Risks of Formaldehyde
- Known Carcinogen: Formaldehyde is a well-established human carcinogen linked to an increased risk of hormone-related cancers, including uterine, ovarian, and breast cancers.
- Other Health Effects: Chronic exposure can cause respiratory irritation, skin sensitization, and chronic conditions like asthma.
- Uterine Fibroids: Frequent use of chemical straighteners is also associated with uterine fibroids, which can lead to infertility, heavy bleeding, and pregnancy loss.
Disproportionate Impact on Black Women
- Targeted Marketing: Hair-straightening products are heavily marketed to Black women, leading to much higher cumulative exposure starting from childhood and adolescence.
- Increased Risk of Fibroids: Black women are up to three times more likely to be diagnosed with uterine fibroids than White women.
- Vulnerability in Salons: Salon workers, many of whom are women of color, face intense occupational exposure to these chemicals as they are heated and inhaled during treatments.
Advocacy and Political Pressure
- Lawmaker Frustration: US Representatives have expressed deep frustration, questioning why the FDA has not acted despite a “mountain of evidence” and years of scientific agreement.
- Citizen Petitions: Since 2021, salon workers and environmental health groups have formally petitioned the FDA to prohibit these ingredients, emphasizing that there is no safe level of exposure in heated consumer products.
- Regulatory Process: Once proposed, the rule must undergo a public comment period and an analysis phase before it can be finalized and enforced.


Leave a comment